Patient Square Capital’s Pharvaris PHVS Stock Holding History
Bought
Maintained
Sold
Other funds holding PHVS
Patient Square Capital's PHVS Position: Q3 2026 in Review
Patient Square Capital increased its Pharvaris (PHVS) stake by 20% in Q3 2026, buying an estimated $4.81M and bringing the position to 808,644 shares worth $25.7M. The position accounts for 4.09% of the portfolio, ranked #5.
Patient Square Capital first reported a position in PHVS in Q3 2024 and has held it in 9 quarters since. 135 funds tracked by Wall St. Rank hold PHVS as of Q3 2026.
- Patient Square Capital held 808,644 shares of Pharvaris worth $25.7M as of Q3 2026.
- Patient Square Capital bought 137,435 Pharvaris shares in Q3 2026, an estimated $4.81M.
- Pharvaris made up 4.09% of Patient Square Capital's portfolio in Q3 2026, its #5 holding.
- Patient Square Capital first reported a position in Pharvaris in Q3 2024 and has held it in 9 quarters since.
- 135 funds tracked by Wall St. Rank held Pharvaris as of Q3 2026.
Based on Patient Square Capital's 13F filing for Q3 2026, filed 10 Nov 2026.